Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

DIREVO Biotech AG

DIREVO Biotech AG is the leading company in the screening-based directed evolution of genes and proteins. Our proprietary platform technologies combine efficient DNA variation methods for mutation and recombination of genes with ultra-high throughput screening technologies. This integrated DIREVO Process is fully automated and works in highly miniaturized formats with throughput rates of up to millions of isolated protein variants per day in most application-relevant assays. DIREVO has built up a dominant position in the screening-based directed evolution which is based on a strong IP position. The DIREVO Process is covered by more than 40 patent and license families. With its rapid and highly flexible screening-based directed evolution process, DIREVO has a broad access to several multi-billion dollar markets such as protein pharmaceuticals, industrial enzymes, chemical biocatalysts as well as proteins for the food and the agricultural sector. Within these markets, DIREVO is currently working on several product developments which offer high-value opportunities.


Contact Details:
Nattermannallee 1
Cologne
D - 50829
Germany
Tel:49 221-8887-0
Fax:49 221-8887-111
Email:ice@direvo.de
WWW:

www.direvo.de/




Recent Publications by DIREVO Biotech AG:

Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis?
The Rho guanine nucleotide exchange factor GEF-H1 is uniquely regulated by...
8th August, 2008
Direvo Biotech AG, Nattermannallee 1, D-50829 Cologne, Germany. Trends Cell Biol. 2008 May;18(5):210-9. Epub 2008 Apr 3.
DOI Direct Link

BioNews Results for DIREVO Biotech AG:

Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 4:27AM Matching: direvo biotech ag
Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 4:26AM Matching: direvo biotech ag

DIREVO Biotech AG Patents:

US Patent No.Title
7170598 Multi-parameter fluorimetric analysis in a massively parallel multi-focal arrangement and the use thereof
6821758 Method for the production of biopolymers with modified properties

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 319 times since April 2007, the link to the organisation's website has been followed 50 times

Search for more companies in Cologne

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DIREVO Biotech AG

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.